StockGuru Blog: Genesis Technology – Hepatitis B Vaccine in Gigantic Demand
GTEC Focus on Hepatitis B - There is Huge Demand GTEC Stock Guru Profile WHO and UNICEF Are Helping China Battle Cause of Deadly Liver Cancer, Achieving Dramatic Increase in Delivery of Vaccines to Most Remote Provinces WHO and UNICEF Are Helping China Battle Cause of Deadly Liver Cancer, Achieving Dramatic Increase in Delivery of Vaccines to Most Remote Provinces Currently, Genesis owns 8.5 million shares in Gold Horse International and 6.7 million shares in Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc. has advanced in the development of a treatment for Hepatitis B and also increased its number of local outlets…